Séguin Béatrice, Hardy Billie-Jo, Singer Peter A, Daar Abdallah S
Béatrice Séguin is also at the Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2, Canada.
Nat Rev Genet. 2008 Oct;9 Suppl 1:S5-9. doi: 10.1038/nrg2442.
In 2004, the government of Mexico established the National Institute of Genomic Medicine (INMEGEN), to carry out disease-related genomic studies that will address national health problems and stimulate scientific and technological development by generating new commercial products and services in genomic medicine. Towards this end, INMEGEN is carrying out a large-scale genotyping project to map genomic variation within its own population. The initiative is expected to generate a key resource for local researchers to understand disease susceptibility and variation in drug responses, which will contribute to Mexico's goal of developing public health genomics - a field in which Mexico is proving to be a leader amongst emerging economies.
2004年，墨西哥政府成立了国家基因组医学研究所（INMEGEN），以开展与疾病相关的基因组研究，解决国家卫生问题，并通过开发基因组医学领域的新商业产品和服务来促进科技发展。为此，INMEGEN正在开展一个大规模基因分型项目，以绘制其本国人群的基因组变异图谱。该项目有望为当地研究人员提供关键资源，助其了解疾病易感性和药物反应差异，这将有助于墨西哥实现发展公共卫生基因组学的目标——在这一领域，墨西哥已证明自己是新兴经济体中的佼佼者。
